Herpes gestationis, second trimester
ICD-10 O26.42 is a billable code used to indicate a diagnosis of herpes gestationis, second trimester.
Herpes gestationis, also known as pemphigoid gestationis, is an autoimmune blistering disorder that typically arises during the second trimester of pregnancy. It is characterized by the development of itchy, blistering lesions that often begin on the abdomen and can spread to other areas of the body. The condition is thought to be related to the body's immune response to placental proteins, leading to the formation of antibodies that attack the skin. While herpes gestationis is not directly harmful to the fetus, it can cause significant discomfort for the mother and may lead to complications such as preterm birth if severe. Management typically involves the use of topical corticosteroids and antihistamines to alleviate symptoms. Close monitoring is essential, especially in cases where the condition is severe or recurrent, as it may require systemic treatment. Understanding the implications of herpes gestationis is crucial for obstetric care providers to ensure both maternal comfort and fetal safety.
Detailed documentation of the patient's symptoms, treatment plans, and any complications that arise.
A pregnant patient presenting with severe itching and blistering lesions on the abdomen during the second trimester.
Consideration of the patient's overall health and any comorbid conditions that may complicate treatment.
Comprehensive documentation of maternal-fetal interactions and any potential risks to the fetus.
Management of a high-risk pregnancy where herpes gestationis is present, requiring close monitoring.
Assessment of the impact of the condition on fetal development and delivery planning.
Used for follow-up visits for management of herpes gestationis during pregnancy.
Documentation of symptoms, treatment response, and any changes in management.
Obstetricians should ensure that all visits are well-documented to support the coding of O26.42.
Accurate coding of O26.42 is crucial for ensuring appropriate management of herpes gestationis during pregnancy. It helps in tracking maternal health outcomes and ensuring that patients receive the necessary care and treatment.
